AutoGenomics launches INFINITIŽ H. pylori Assay for detection of Helicobacter pylori and mutations at 2142G & 2143G that are associated with antibiotic resistance.
AutoGenomics enters into Distribution Agreement with McKesson Medical-Surgical Inc. to distribute AutoGenomics' proprietary INFINITI Systems and reagents.
AutoGenomics, Inc., a leader in providing automated molecular testing solutions to clinical laboratories, announced today that it will showcase its "Sample-to-Result" NextGen automation platform - INFINITIŽ SMART - at the American Association for Clinical Chemistry Meeting (AACC) in Atlanta, to be held from July 28 - 30, 2015.
AutoGenomics, Inc., a leader in providing automated molecular testing solutions, announced today that it has launched a test for Genotyping Hepatitis C Virus (HCV) on its INFINITIŽ Plus and INFINITIŽ High Throughput System (HTS).